BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22139722)

  • 1. Contrast-induced nephropathy: controlled study by differential GFR measurement in hospitalized patients.
    Erselcan T; Egilmez H; Hasbek Z; Tandogan I
    Acta Radiol; 2012 Mar; 53(2):228-32. PubMed ID: 22139722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probability of reduced renal function after contrast-enhanced CT: a model based on serum creatinine level, patient age, and estimated glomerular filtration rate.
    Herts BR; Schneider E; Obuchowski N; Poggio E; Jain A; Baker ME
    AJR Am J Roentgenol; 2009 Aug; 193(2):494-500. PubMed ID: 19620448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of contrast material-induced nephropathy after neuroendovascular procedures.
    Prasad V; Gandhi D; Stokum C; Miller T; Jindal G
    Radiology; 2014 Dec; 273(3):853-8. PubMed ID: 25102293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of contrast-induced nephropathy in trauma patients.
    Hipp A; Desai S; Lopez C; Sinert R
    Eur J Emerg Med; 2008 Jun; 15(3):134-9. PubMed ID: 18460952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium bicarbonate versus normal saline for protection against contrast nephropathy.
    Budhiraja P; Chen Z; Popovtzer M
    Ren Fail; 2009; 31(2):118-23. PubMed ID: 19212908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
    Nguyen SA; Suranyi P; Ravenel JG; Randall PK; Romano PB; Strom KA; Costello P; Schoepf UJ
    Radiology; 2008 Jul; 248(1):97-105. PubMed ID: 18483232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the Cockcroft-Gault and modification of diet in renal disease equations in estimating GFR in ill hospitalized patients.
    Poggio ED; Nef PC; Wang X; Greene T; Van Lente F; Dennis VW; Hall PM
    Am J Kidney Dis; 2005 Aug; 46(2):242-52. PubMed ID: 16112042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-induced nephropathy risk due to emergency contrast-enhanced computed tomography.
    Durukan P; Ozkan S; Ikizceli I; Vardar A; Ipekci A; Duman A
    Eur J Emerg Med; 2012 Feb; 19(1):20-3. PubMed ID: 21552131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
    Solomon RJ; Natarajan MK; Doucet S; Sharma SK; Staniloae CS; Katholi RE; Gelormini JL; Labinaz M; Moreyra AE;
    Circulation; 2007 Jun; 115(25):3189-96. PubMed ID: 17562951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention.
    Zhang J; Fu X; Jia X; Fan X; Gu X; Li S; Wu W; Fan W; Su J; Hao G; Jiang Y; Xue L
    Acta Radiol; 2010 Jul; 51(6):641-8. PubMed ID: 20438292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy.
    Cirit M; Toprak O; Yesil M; Bayata S; Postaci N; Pupim L; Esi E
    Nephron Clin Pract; 2006; 104(1):c20-7. PubMed ID: 16685140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
    Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
    Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
    Solomon R; Dumouchel W
    Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative investigation of i.v. iohexol and iopamidol: effect on renal function in low-risk outpatients undergoing CT.
    Dillman JR; al-Hawary M; Ellis JH; Cohan RH; Kaza R; Myles JD; Khalatbari S; Francis IR
    AJR Am J Roentgenol; 2012 Feb; 198(2):392-7. PubMed ID: 22268183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of Diet in Renal Disease equation in the risk stratification of contrast induced acute kidney injury in hospital inpatients.
    Erselcan T; Hasbek Z; Tandogan I; Gumus C; Akkurt I
    Nefrologia; 2009; 29(5):397-403. PubMed ID: 19820751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Tc-99m-DTPA nuclear medicine GFR studies in pediatric solid tumor patients.
    Gibson P; Shammas A; Cada M; Licht C; Gupta AA
    J Pediatr Hematol Oncol; 2013 Mar; 35(2):108-11. PubMed ID: 22767127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of gadolinium diethylene triamine penta-acetic acid, as measured by ELISA, in the determination of glomerular filtration rates in cats.
    Sox EM; Chiotti R; Goldstein RE
    J Feline Med Surg; 2010 Oct; 12(10):738-45. PubMed ID: 20724186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of theophylline in contrast-induced nephropathy: a case-control study.
    Kapoor A; Kumar S; Gulati S; Gambhir S; Sethi RS; Sinha N
    Nephrol Dial Transplant; 2002 Nov; 17(11):1936-41. PubMed ID: 12401850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of nephroprotection by the selection of contrast media used during vascular interventions in patients with chronic renal failure?].
    Schönefeld E; Höwler S; Osada N; Torsello G
    Zentralbl Chir; 2011 Oct; 136(5):426-30. PubMed ID: 22009540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.
    Nyman U; Björk J; Aspelin P; Marenzi G
    Acta Radiol; 2008 Jul; 49(6):658-67. PubMed ID: 18568558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.